Peter Webborn

Dr. Peter Webborn has 30 years of experience in the pharmaceutical industry having held a number of senior positions within AstraZeneca, including Head of DMPK, Drug Safety and Metabolism; Director of Pharmacokinetics and Mass Spectrometry Imaging, and DMPK Director of the Centre of Excellence: Discovery/ Early Development. Peter was DMPK lead on AZ’s P2Y12 franchise that yielded Brilinta® (ticagrelor) and Kengreal® (cangrelor). Peter’s expertise in DMPK and his broad experience with both the tactical and strategic running of drug discovery and development projects are highly aligned with Mironid’s Biology and Medicinal Chemistry teams.